Clinical Trials in Seattle

Showing 2981-3000 of 8,049 trials

HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions

NCT03051516

This phase IV trial studies how well human papillomavirus (HPV) vaccine therapy works in interrupting progression in patients with high-grade vulvar or anal lesions. Vaccines made from HPV peptides or antigens may help the body build an effective immune response to kill tumor cells and decrease the chance of vulvar or anal lesions to progress or come back.

High Grade Anal Canal Intraepithelial NeoplasiaHigh Grade Vulvar Squamous Intraepithelial Lesion

Fred Hutchinson Cancer Center188 participantsStarted Aug 2017

Birmingham, Alabama, United States • Seattle, Washington, United States

COMPLETEDPhase 1< 1 mile

A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread

NCT04540705

The purpose of this study is in Part 1, to determine the safety of nivolumab, bempegaldesleukin (BEMPEG: NKTR-214), and Tyrosine Kinase Inhibitor (TKI) combination.

Renal Cell Carcinoma

Bristol-Myers Squibb30 participantsStarted Sep 2020

Springdale, Arkansas, United States • Louisville, Kentucky, United States • St Louis, Missouri, United States +36 more locations

HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions

A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread

Find Trials by Condition in Seattle

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer

Gene Therapy With hLB-001 in Pediatric Patients With Severe Methylmalonic Acidemia

Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma

A Test-Drive Strategy for the Prescription of Prosthetic Feet for People With Leg Amputations

Pediatric KIDney Stone (PKIDS) Care Improvement Network

Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)

A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)

Pilot Prospective Study: Long-term Health of Living Kidney Donors

Nivolumab Ipilimumab in Patients With hyperMutated Cancers Detected in Blood (NIMBLe)

A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis

Phase 3 Study of SNF472 for Calciphylaxis

Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM

Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)